Table: The Top Performers

These equity funds have received the top grade in BusinessWeek's Offshore Fund Scoreboard. To achieve the A grade, a fund must deliver superior risk- adjusted total returns for five years. Several of these funds have received AAA ratings from Standard & Poor's Fund Research for performance relative to others in their sector. They are marked with an asterisk.

FUND SECTOR ASSETS (millions RETURNS** of U.S. 1 YEAR 5 YEAR dollars)

VONTOBEL FD U.S. VALUE EQUITY B U.S. $221 17.89 14.70 SOCGEN INTERNATIONAL SICAV Global 173 6.01 8.95 BBL (L) INV HEALTHCARE C Healthcare Global 137 -8.43 11.06 SEB LUX (F)-LAKEMEDELS-OCH BIO Healthcare Global 207 -11.69 12.53 JB U.S. LEADING STOCK FUND B U.S. 563 -15.78 11.24 FIDELITY FDS EUROPEAN GTH Europe 6316 -16.14 12.75 M.LYNCH U.S. FOCUSED VALUE A North America 148 -17.01 15.90 MERCURY OST UNITED KINGDOM U.K. 579 -17.95 15.60 DIT-DRESDNER U.S. EQUITY U.S. 138 -18.64 13.60 OPPENHEIM PHARMA/WHEALTH Healthcare Global 575 -18.76 18.93 INVESCO GT LEISURE A Leisure Global 216 -22.90 11.60 SCHRODER ISF ITALIAN EQY A Italy 384 -27.30 23.10 HSBC GIF PAN-EURO EQUITY A Europe 751 -27.77 12.41 GARTMORE CSF CONT'L EUROPE* Europe ex-U.K. 2326 -28.06 13.04 HSBC GIF EUROPEAN EQUITY A Europe ex-U.K. 234 -28.54 11.58 M.LYNCH GLOBAL SMALLCAP A Global sm.cos 224 -28.82 20.04 CS EF (LUX) USA B U.S. 2333 -32.57 11.62 HENDERSON HF EUROPEAN* Europe ex-U.K. 757 -34.45 13.36 ROLINCO N.V Global 2127 -34.96 18.55 PICTET G.S.F. BIOTECH P Biotechnology 1627 -37.26 21.51 FLEMING FRONTIER EURO DISCOV* Europe ex-U.K. sm.cos 127 -57.51 19.76

** Through Oct. 1, 2001, including price appreciation and reinvestment of dividends and capital gains

Data: Standard & Poor's

    Before it's here, it's on the Bloomberg Terminal.
    LEARN MORE